Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection

Gastroenterology

Volumn 139, Issue 5, 2010, Pages 1612-1618

  Kamar, Nassim ^a,b   Rostaing, Lionel ^a,b,c   Abravanel, Florence ^b,c   Garrouste, Cyril ^a   Lhomme, Sebastien ^c   Esposito, Laure ^a   Basse, Grégoire ^a,b   Cointault, Olivier ^a   Ribes, David ^a   Nogier, Marie Béatrice ^a   Alric, Laurent ^c   Peron, Jean Marie ^b,c   Izopet, Jacques ^b,c  

^a CHU RANGUEIL   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c CHU PURPAN   (France)

Author keywords

Chronic Hepatitis; Immune Suppression; SVR; Viral Infections

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; PEGINTERFERON ALPHA; RIBAVIRIN; VIRUS RNA;

ADULT; AGED; ANEMIA; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CREATININE CLEARANCE; DRUG DOSE REDUCTION; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MONOTHERAPY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RELAPSE; TREATMENT CONTRAINDICATION; TREATMENT RESPONSE; VIRUS CONCENTRATION; VIRUS DETECTION; VIRUS REPLICATION;

EID: 78049469347     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.08.002     Document Type: Article

References (27)

1. N. Kamar, J. Selves, and J.M. Mansuy Hepatitis E virus and chronic hepatitis in organ-transplant recipients N Engl J Med 358 2008 811 817
2. R. Gerolami, V. Moal, and P. Colson Chronic hepatitis E with cirrhosis in a kidney-transplant recipient N Engl J Med 358 2008 859 860
3. E.B. Haagsma, A.P. van den Berg, and R.J. Porte Chronic hepatitis E virus infection in liver transplant recipients Liver Transpl 14 2008 547 553
4. N. Kamar, J.M. Mansuy, and O. Cointault Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients Am J Transplant 8 2008 1744 1748
5. L. Ollier, N. Tieulie, and F. Sanderson Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab Ann Intern Med 150 2009 430 431
6. R. Gerolami, V. Moal, C. Picard, and P. Colson Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients J Hepatol 50 2009 622 624
7. H.R. Dalton, R. Bendall, F. Keane, R. Tedder, and S. Ijaz Persistent carriage of hepatitis E virus in patients with HIV infection N Engl J Med 361 2009 1025 1027
8. P. Colson, M. Kaba, J. Moreau, and F. Brouqui Hepatitis E in an HIV-infected patient J Clin Virol 45 2009 269 271
9. N. Kamar, F. Abravanel, and J. Selves Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation Transplantation 89 2010 353 360
10. N. Kamar, L. Rostaing, and F. Abravanel Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation Clin Infect Dis 50 2010 e30 e33
11. E.B. Haagsma, A. Riezebos-Brilman, A.P. van den Berg, R.J. Porte, and H.G. Niesters Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b Liver Transpl 16 2010 474 477
12. N. Kamar, F. Abravanel, and C. Garrouste Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient Nephrol Dial Transplant 25 2010 2792 2795
13. L. Alric, D. Bonnet, G. Laurent, N. Kamar, and J. Izopet Chronic hepatitis E virus infection: successful virologic response to pegylated interferon-{alpha} therapy Ann Intern Med 153 2010 135 136
14. L. Rostaing, J. Izopet, E. Baron, M. Duffaut, J. Puel, and D. Durand Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients Transplantation 59 1995 1426 1431
15. Kidney Disease Improving Global Outcomes (KDIGO) KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease Kidney Int Suppl 2008 S1 S99
16. N. Kamar, K. Sandres-Saune, and J. Selves Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology Am J Kidney Dis 42 2003 184 192
17. H. Fontaine, A. Vallet-Pichard, and S. Pol Histopathological efficacy of ribavirin monotherapy in hepatitis C virus positive renal transplant patients Transplantation 79 2005 1771
18. J.M. Mansuy, F. Legrand-Abravanel, and J.P. Calot High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France J Med Virol 80 2008 289 293
19. P. Bedossa, T. Poynard The METAVIR Cooperative Study Group An algorithm for the grading of activity in chronic hepatitis C Hepatology 24 1996 289 293
20. J.M. Mansuy, J.M. Peron, and F. Abravanel Hepatitis E in the south west of France in individuals who have never visited an endemic area J Med Virol 74 2004 419 424
21. F. Legrand-Abravanel, J.M. Mansuy, and M. Dubois Hepatitis E virus genotype 3 diversity, France Emerg Infect Dis 15 2009 110 114
22. V. Mallet, E. Nicand, and P. Sultanik Brief communication: case reports of ribavirin treatment for chronic hepatitis E Ann Intern Med 153 2010 85 89
23. R.W. Sidwell, J.H. Huffman, G.P. Khare, L.B. Allen, J.T. Witkowski, and R.K. Robins Broad-spectrum antiviral activity of Virazole: 1-beta-D- ribofuranosyl-1,2,4-triazole-3-carboxamide Science 177 1972 705 706
24. J.L. Patterson, and R. Fernandez-Larsson Molecular mechanisms of action of ribavirin Rev Infect Dis 12 1990 1139 1146
25. A. Bruchfeld, K. Lindahl, R. Schvarcz, and L. Stahle Dosage of ribavirin in patients with hepatitis C should be based on renal function: a population pharmacokinetic analysis Ther Drug Monit 24 2002 701 708
26. N. Kamar, E. Chatelut, E. Manolis, T. Lafont, J. Izopet, and L. Rostaing Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal function Am J Kidney Dis 43 2004 140 146
27. N. Brau Epoetin alfa treatment for acute anaemia during interferon plus ribavirin combination therapy for chronic hepatitis C J Viral Hepat 11 2004 191 197